A Randomized Clinical Trial of Trimetazidine, a Partial Free Fatty Acid Oxidation Inhibitor, in Patients With Heart Failure

This publication has 44 references indexed in Scilit:

• Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy
  American Journal of Physiology-Endocrinology and Metabolism, 2006
• Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy
  Heart, 2005
• Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease
  European Heart Journal, 2004
• Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy
  American Heart Journal, 2003
• Blood Ketone Bodies in Congestive Heart Failure
  Journal of the American College of Cardiology, 1996
• Improvement of Long-Term Preservation of the Isolated Arrested Rat Heart By Trimetazidine: Effects on the Energy State and Mitochondrial Function
  The American Journal of Cardiology, 1995
• Combination Therapy of Trimetazidine with Diltiazem in Patients with Coronary Artery Disease
  The American Journal of Cardiology, 1995
• The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia
  Molecular and Cellular Biochemistry, 1992
• Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing
  The American Journal of Cardiology, 1977
• Beta adrenergic blockade: Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease
  The American Journal of Cardiology, 1968